← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 25, 2018Last known activity
Dec 12, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT06701136Lead sponsorPhase 1Dec 12, 2024
- NCT06701110Lead sponsorPhase 1Sep 4, 2024
- NCT06124963Lead sponsorPhase 2Aug 25, 2023
- NCT06117566Lead sponsorPhase 1/Phase 2Nov 18, 2022
- NCT05824871Lead sponsorPhase 3Sep 2, 2022
- NCT06132932Lead sponsorPhase 1/Phase 2Jun 3, 2021
- NCT06117540Lead sponsorPhase 2May 11, 2021
- NCT04608955Lead sponsorPhase 2Nov 1, 2020
- NCT04608955Study chairPhase 2Nov 1, 2020
- NCT06117514Lead sponsorPhase 1Feb 13, 2019
- NCT03730142Lead sponsorPhase 1Oct 25, 2018
Details
- Last known activity
- Dec 12, 2024